BridgeBio Pharma, Inc. (BBIO)
78.32
+1.75
(+2.29%)
USD |
NASDAQ |
Sep 02, 09:41
BridgeBio Pharma Net Income (TTM) : -702.02M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -702.02M |
| March 31, 2026 | -729.88M |
| December 31, 2025 | -732.94M |
| September 30, 2025 | -805.69M |
| June 30, 2025 | -785.01M |
| March 31, 2025 | -676.80M |
| December 31, 2024 | -543.35M |
| September 30, 2024 | -446.29M |
| June 30, 2024 | -461.52M |
| March 31, 2024 | -546.68M |
| December 31, 2023 | -653.25M |
| September 30, 2023 | -623.49M |
| June 30, 2023 | -584.20M |
| March 31, 2023 | -426.05M |
| December 31, 2022 | -484.65M |
| September 30, 2022 | -496.36M |
| Date | Value |
|---|---|
| June 30, 2022 | -517.19M |
| March 31, 2022 | -616.70M |
| December 31, 2021 | -586.45M |
| September 30, 2021 | -569.20M |
| June 30, 2021 | -538.35M |
| March 31, 2021 | -572.49M |
| December 31, 2020 | -505.49M |
| September 30, 2020 | -454.61M |
| June 30, 2020 | -385.11M |
| March 31, 2020 | -323.23M |
| December 31, 2019 | -288.58M |
| September 30, 2019 | -253.68M |
| June 30, 2019 | -235.09M |
| March 31, 2019 | -196.46M |
| December 31, 2018 | -169.45M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| Ionis Pharmaceuticals, Inc. | -564.78M |
| Pfizer Inc. | 4.373B |
| Vertex Pharmaceuticals, Inc. | 4.405B |
| BioMarin Pharmaceutical, Inc. | 72.97M |